Lymphedema Therapy, Woodbury, NY 11797, USA.
Semin Oncol Nurs. 2013 Feb;29(1):20-7. doi: 10.1016/j.soncn.2012.11.004.
To summarize current evidence on the management of lymphedema and to provide management recommendations.
Eleven databases, including PubMed and CINAHL from 2004-2011.
Complete decongestive therapy (CDT) is effective in reducing lymphedema, although the contribution of each individual complete decongestive therapy component has not been determined. In general, levels of evidence for complete decongestive therapy are mid-level.
Oncology nurses and health care providers play key roles in assessing needs and prescribing interventions to support patients with lymphedema from admission to discharge. Reviewing risk-reduction strategies and supporting the patient with lymphedema to continue self-care when undergoing medical treatment empowers patients to be proactive in health maintenance. Identifying potential problems and making appropriate referral to a lymphedema specialist avoids triggering or worsening lymphedema.
总结目前关于淋巴水肿管理的证据，并提供管理建议。
2004 年至 2011 年间，11 个数据库，包括 PubMed 和 CINAHL。
完整的消肿治疗（CDT）可有效减少淋巴水肿，尽管尚未确定每个完整的消肿治疗组成部分的贡献。总的来说，完整的消肿治疗的证据水平为中级。
肿瘤护士和医疗保健提供者在评估需求和开出处方干预措施方面发挥着关键作用，以支持从入院到出院的淋巴水肿患者。审查降低风险的策略，并支持患有淋巴水肿的患者在接受治疗时继续自我护理，使患者能够积极主动地进行健康维护。发现潜在问题并向淋巴水肿专家进行适当转介可避免引发或加重淋巴水肿。
